Skip to main content
. 2020 Nov 28;10(11):297–306. doi: 10.5500/wjt.v10.i11.297

Figure 2.

Figure 2

First- and second-line therapies for advanced hepatocellular carcinoma that may be applicable in the post-liver transplantation setting.